XNAS · Laboratory Analytical Instruments · S&P 500
$4.01
+$0.25 (+6.52%) today
Open $3.76 High $4.05 Low $3.76 Vol 33K Avg $3.97
Find similar stocks by technical condition — S&P 500 universe
| Symbol | Company Name | Exchange | Currency | Category |
|---|---|---|---|---|
| NEWP | New Pacific Metals Corp. | XASE | USD | - |
| IAG | IAMGold Corporation | XNYS | USD | - |
| BHST | BioHarvest Sciences Inc. Common Stock | XNAS | USD | - |
| BLDP | Ballard Power Systems Inc. | XNAS | USD | - |
| CHY | Calamos Convertible and High Income Fund | XNAS | USD | - |
| AEC | Anfield Energy Inc. Common Shares | XNAS | USD | - |
| GCDT | Green Circle Decarbonize Technology Limited | XASE | USD | - |
| OXLC | Oxford Lane Capital Corp. | XNAS | USD | - |
| DTSS | Datasea Intelligent Technology Ltd. Class A Ordinary Shares | XNAS | USD | - |
| SOS | SOS Limited | XNYS | USD | - |
52-week price range
Price is 12.2% above its 52-week low and 68.7% below its 52-week high. Trading in the lower half of its annual range — closer to the floor than the ceiling.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.